Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
์ข
๋ชฉ ์ฝ๋ ACONW
ํ์ฌ ์ด๋ฆAclarion Inc
์์ฅ์ผApr 22, 2022
CEOMr. Brent Ness
์ง์ ์- -
์ ํCompany Warrant
ํ๊ณ ์ฐ๋ ์ข
๋ฃ- -
์ฃผ์8181 Arista Place
๋์BROOMFIELD
์ฆ๊ถ ๊ฑฐ๋์NASDAQ Capital Market Consolidated
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ80021
์ ํ18332752266
์น์ฌ์ดํธhttps://aclarion.com/
์ข
๋ชฉ ์ฝ๋ ACONW
์์ฅ์ผApr 22, 2022
CEOMr. Brent Ness
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์